首页> 外文期刊>european journal of immunology >Mechanisms in CD4 antibody‐mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells
【24h】

Mechanisms in CD4 antibody‐mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells

机译:CD4抗体介导的移植耐受性机制:诱导动力学、抗原依赖性和调节性T细胞的作用

获取原文
获取外文期刊封面目录资料

摘要

AbstractCBA/Ca mice may be made tolerant to minor histoincompatible B10.BR skin grafts by treatment with a short course of non‐depleting anti‐mouse CD4 and CD8 monoclonal antibodies (mAb), during the transplantation period. We wished to determine when, in relation to antibody therapy, the T cells became tolerant. This was investigated by a series of adoptive transfer experiments in which mAb‐treated cells were removed from therapeutic antibody at defined times after skin grafting, and exposed to fresh antigen in the absence of further mAb treatment. We show here that T cells do not become fully tolerant until 5 weeks after skin grafting. If antibody therapy is continued for the full 5 weeks, T cell tolerance can still be established, suggesting that antibody therapy does not prevent lymphocytes from registering the presence of antigen. Once the tolerant state is established, it is difficult to break that tolerance by lymphocyte infusions from normal donors. This “resistance” is mediated by T cells of the tolerant host. We show that the maintenance of both tolerance and “resistance” requires a continuous supply of antigen. When tolerant cells were “parked” in T celldepleted mice, tolerance and “resistance” were eventually lost by 6 months. In contrast, “parked” cells exposed to fresh antigen at any time up to 4 months remained tolerant and “resistant” indefinitely. Finally, we wished to establish whether “resistance” was peculiar to this form ofperipheraltolerance, or whether it might also be present in tolerance considered to be classicallycentral.We observed resistance to be greater in the mAb‐treated peripherally tolerant group, but noted that some of the centrally tolerant animals also exhibited a level of resistance above that of T cell‐ablated controls. This suggests that a tolerance mechanism whose role is only minor in central tolerance may have a major role in a
机译:摘要 在移植期间,通过短期非耗竭性抗小鼠CD4和CD8单克隆抗体(mAb)治疗,CBA/Ca小鼠可以耐受轻微的组织不相容 B10.BR 皮肤移植物。我们希望确定与抗体治疗相关的T细胞何时变得耐受。这是通过一系列过继转移实验进行的,在这些实验中,在皮肤移植后的特定时间将mAb处理的细胞从治疗性抗体中去除,并在没有进一步mAb处理的情况下暴露于新鲜抗原。我们在这里表明,T细胞直到皮肤移植后5周才完全耐受。如果抗体治疗持续整整 5 周,仍可建立 T 细胞耐受性,这表明抗体治疗不会阻止淋巴细胞记录抗原的存在。一旦建立了耐受状态,就很难通过从正常供体输注淋巴细胞来打破这种耐受性。这种“耐药性”是由耐受宿主的T细胞介导的。我们表明,维持耐受性和“耐药性”需要持续供应抗原。当耐受细胞“停放”在T细胞耗尽的小鼠中时,耐受性和“抵抗力”最终在6个月时丧失。相比之下,在长达 4 个月的任何时间暴露于新鲜抗原的“停放”细胞无限期地保持耐受性和“耐药性”。最后,我们希望确定“抵抗”是否是这种形式的外围宽容所特有的,或者它是否也可能存在于被认为是经典核心的宽容中。我们观察到mAb处理的外周耐受组的耐药性更大,但注意到一些中枢耐受的动物也表现出高于T细胞消融对照组的耐药水平。这表明,在中枢公差中作用较小的公差机制可能在

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号